Drug treatment for multidrug-resistant Acinetobacter baumannii infections.
about
Structure determination of LpxA from the lipopolysaccharide-synthesis pathway ofAcinetobacter baumanniiStructure determination of LpxD from the lipopolysaccharide-synthesis pathway ofAcinetobacter baumanniiNecrotizing fasciitis caused by Acinetobacter baumannii : A case reportSynergistic Effect of Oleanolic Acid on Aminoglycoside Antibiotics against Acinetobacter baumanniiThe antibacterial properties of Malaysian tualang honey against wound and enteric microorganisms in comparison to manuka honeyDetection of KPC in Acinetobacter spp. in Puerto Rico.Therapeutic drug monitoring of amikacin in septic patients.Multidrug-resistant Acinetobacter baumannii infection in childrenTwo methionine aminopeptidases from Acinetobacter baumannii are functional enzymes.Piscidin is highly active against carbapenem-resistant Acinetobacter baumannii and NDM-1-producing Klebsiella pneumonia in a systemic Septicaemia infection mouse modelMolecular identification of Acinetobacter baumannii isolated from intensive care units and their antimicrobial resistance patterns.A 4-year surveillance of antimicrobial resistance patterns of Acinetobacter baumanni in a university-affiliated hospital in China.Homeostasis of glutathione is associated with polyamine-mediated β-lactam susceptibility in Acinetobacter baumannii ATCC 19606The Impact of Antibiotic Consumption on Development of Acinetobacter Baumannii Resistance.Synergistic effects and antibiofilm properties of chimeric peptides against multidrug-resistant Acinetobacter baumannii strains.Treatment of Acinetobacter infections.National Survey of Thai Infectious Disease Physicians on Treatment of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia: The Role of Infection Control Awareness.Tuning the activity of a short arg-trp antimicrobial Peptide by lipidation of a C- or N-terminal lysine side-chain.Antibiotic resistance and carriage class 1 and 2 integrons in clinical isolates of Acinetobacter baumannii from Tehran, Iran.Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health system.Cloning, Expression, and Purification of Nucleoside Diphosphate Kinase from Acinetobacter baumannii.Patient specific risk stratification for antimicrobial resistance and possible treatment strategies in gram-negative bacterial infections.Task force on management and prevention of Acinetobacter baumannii infections in the ICU.Studies on New Delhi Metallo-Beta-Lactamse-1 producing Acinetobacter baumannii isolated from donor swab in a tertiary eye care centre, India and structural analysis of its antibiotic binding interactions.Potent β-Lactam Enhancer Activity of Zidebactam and WCK 5153 against Acinetobacter baumannii, Including Carbapenemase-Producing Clinical Isolates.Molecular modeling studies to explore the binding affinity of virtually screened inhibitor toward different aminoglycoside kinases from diverse MDR strains.Efficacy of intravenous plus intrathecal/intracerebral ventricle injection of polymyxin B for post-neurosurgical intracranial infections due to MDR/XDR Acinectobacter baumannii: a retrospective cohort study.Trans-Cinnamaldehyde and Eugenol Increase Acinetobacter baumannii Sensitivity to Beta-Lactam Antibiotics.Detection of OXA-type carbapenemases and integrons among carbapenem-resistant Acinetobactor baumannii in a Teaching Hospital in ChinaFirst report of colistin resistance among carbapenem-resistant isolates recovered from hospitalized patients in Egypt
P2860
Q27675313-AFC85143-89C8-41CA-AEC8-0D7F82EF3C71Q27675777-BC1C1EF8-88E5-4CD8-B6E4-7072E31D747BQ28293095-BE8539A2-E4AC-4AC5-8B02-1839B5771A47Q28547854-350C047D-A8BF-4599-A7F4-CD94A1871332Q33503390-8C425A25-E559-4ED3-800A-05E89198FF81Q33676198-1CC4DB67-F351-461D-8649-C14C0DD7E997Q33754166-B5A3168B-02ED-4B11-861D-C5EE09B75D5CQ34300419-056911B9-FE62-4BD6-AD88-0C5821029DC7Q34995636-B40B08C7-F77B-4AC6-8A6E-824C9642EF75Q35548903-7C558B90-11E1-45CC-9B00-17723E4B747EQ35884503-B12B3D9E-CC05-4CA1-B185-6AC3F00A6ADAQ37127944-7E84FAF9-C426-4BDD-BCAC-988EC6E74610Q37263500-B9A3E863-EC0F-452C-9F90-F571202FD432Q37588522-90EBF426-A282-451A-8D81-BA78791166F1Q37643714-C9D4AEEA-BCA9-41F8-A20A-F78849A3D11BQ37704397-91C6E3C3-594F-434D-BBE9-B9A558729C76Q38383811-2028B919-CFFB-4EBA-A720-F2D9F63B4F6BQ39731315-E9BF9C18-116D-4143-8669-BF18704D4EB0Q39865670-83F54B85-DF02-4E36-8CF2-A94BF0ABCE51Q39922949-4CDA2086-E52A-4308-A9F6-BB035C8BF50EQ40229350-87E69C3D-FF86-4360-A18D-B8A13FA5677EQ40494723-0451E883-AEE6-4560-A7E2-4A23A05ED6B6Q40965515-D430E277-BA1B-43C4-88E5-E127DD5A1414Q41891252-02149DDD-2E43-4148-A0B3-90E4C9D1896FQ47785464-E0780A87-A010-4E20-8BB2-D2DD51D1BF92Q48051031-95A3E855-2E63-4DDD-B5DC-A7B59BA202A0Q49706174-547AC08A-F1D7-4C30-BC0B-923C13E0325FQ55260699-F9A4EF65-6F89-457B-80FD-D49863DB0C8AQ56385526-4BAE5582-211F-43A4-86AD-2D26B46B7383Q57167678-18E0025B-290B-4151-8B92-A0EA71E44604
P2860
Drug treatment for multidrug-resistant Acinetobacter baumannii infections.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Drug treatment for multidrug-resistant Acinetobacter baumannii infections.
@ast
Drug treatment for multidrug-resistant Acinetobacter baumannii infections.
@en
Drug treatment for multidrug-resistant Acinetobacter baumannii infections.
@nl
type
label
Drug treatment for multidrug-resistant Acinetobacter baumannii infections.
@ast
Drug treatment for multidrug-resistant Acinetobacter baumannii infections.
@en
Drug treatment for multidrug-resistant Acinetobacter baumannii infections.
@nl
prefLabel
Drug treatment for multidrug-resistant Acinetobacter baumannii infections.
@ast
Drug treatment for multidrug-resistant Acinetobacter baumannii infections.
@en
Drug treatment for multidrug-resistant Acinetobacter baumannii infections.
@nl
P2860
P50
P356
P1433
P1476
Drug treatment for multidrug-resistant Acinetobacter baumannii infections
@en
P2093
Matteo Bassetti
Silvano Esposito
P2860
P304
P356
10.2217/17460913.3.6.649
P577
2008-12-01T00:00:00Z